Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12ETN | ISIN: CA98420N1050 | Ticker-Symbol: XP0
Tradegate
26.06.25 | 18:24
27,000 Euro
-2,17 % -0,600
1-Jahres-Chart
XENON PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
XENON PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
27,40027,60020:34
27,40027,60020:32

Aktuelle News zur XENON PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoXenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)20VANCOUVER, British Columbia and BOSTON, June 26, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing...
► Artikel lesen
DiXenon Pharmaceuticals Inc.: Xenon Announces Appointment of Darren Cline as Chief Commercial Officer186VANCOUVER, British Columbia and BOSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing...
► Artikel lesen
05.06.Xenon Pharmaceuticals berichtet über Abstimmungsergebnisse der Aktionäre2
05.06.Xenon Pharmaceuticals Inc. - 8-K, Current Report1
30.05.Xenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)151VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing...
► Artikel lesen
12.05.Xenon Pharmaceuticals Inc. - 10-Q, Quarterly Report1
12.05.Xenon Pharmaceuticals Inc. - 8-K, Current Report1
12.05.Xenon Pharmaceuticals Inc.: Xenon Reports First Quarter 2025 Financial Results and Provides Business Update205- Phase 3 azetukalner X-TOLE2 FOS study patient recruitment expected to complete in the next few months with topline data anticipated in early 2026 - Phase 3 azetukalner X-NOVA3 MDD and Phase 3 BPD...
► Artikel lesen
XENON PHARMACEUTICALS Aktie jetzt für 0€ handeln
09.05.What to Expect from Xenon Pharmaceuticals' Earnings3
07.05.Chardan sets XENE stock Buy rating, $55 target on CNS potential1
05.05.Xenon Pharmaceuticals Inc.: Xenon to Report Q1 2025 Financial Results on May 12, 20251
02.05.Xenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)127VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing...
► Artikel lesen
04.04.Xenon Pharmaceuticals Inc.: Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 20251
17.03.Xenon Pharmaceuticals Inc. - 8-K, Current Report4
12.03.Xenon Pharmaceuticals Inc.: Xenon to Present at Stifel 2025 Virtual CNS Forum1
05.03.Xenon Pharmaceuticals Inc. - 8-K, Current Report1
27.02.Xenon Pharmaceuticals Inc. - S-8, Securities to be offered to employees in employee benefit plans-
27.02.Xenon Pharmaceuticals Inc.: Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update226- Phase 3 topline data from azetukalner FOS epilepsy program planned for H2 2025 in support of NDA filing and potential commercial launch - First of three planned Phase 3 azetukalner MDD studies...
► Artikel lesen
27.02.Xenon Pharmaceuticals Inc. - 10-K, Annual Report-
20.02.Xenon Pharmaceuticals Inc.: Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 20251
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1